Sei v6.4 is now live on mainnet. The update brings IBC disable capability as the chain moves toward an EVM-only future under SIP-3.
Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept into one of oncology’s most dynamic therapeutic classes. By fusing the targeting specificity of monoclonal antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results